ABLE Trademark

Trademark Overview


On Monday, February 23, 2026, a trademark application was filed for ABLE with the United States Patent and Trademark Office. The USPTO has given the ABLE trademark a serial number of 99665717. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, June 4, 2026. This trademark is owned by Proteintech Group, Inc.. The ABLE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring artificial intelligence (AI) software for generating antibody and antigen analysis report; Software as a service (SAAS) services featuring artificial intelligence software for analyzing antibody data; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for antibody analysis; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for antibody data exploration; Artificial intelligence as a service (AIaaS) for technical consultation and support in the field of antibody; providing online non-downloadable software using artificial intelligence for interactive customer services to find and construct suitable antibody, protein, related products for life science research; artificial intelligence consultancy in the field of antibody and protein research; Software as a service (SAAS) services for analyzing antibody-related technical issues.

General Information


Serial Number99665717
Word MarkABLE
Filing DateMonday, February 23, 2026
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, June 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware as a service (SAAS) services featuring artificial intelligence (AI) software for generating antibody and antigen analysis report; Software as a service (SAAS) services featuring artificial intelligence software for analyzing antibody data; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for antibody analysis; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for antibody data exploration; Artificial intelligence as a service (AIaaS) for technical consultation and support in the field of antibody; providing online non-downloadable software using artificial intelligence for interactive customer services to find and construct suitable antibody, protein, related products for life science research; artificial intelligence consultancy in the field of antibody and protein research; Software as a service (SAAS) services for analyzing antibody-related technical issues.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 23, 2026
Primary Code042
First Use Anywhere DateTuesday, January 13, 2026
First Use In Commerce DateTuesday, January 13, 2026

Trademark Owner History


Party NameProteintech Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRosemont, IL 60018
US

Trademark Events


Event DateEvent Description
Monday, February 23, 2026NEW APPLICATION ENTERED
Monday, February 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 23, 2026APPLICATION FILING RECEIPT MAILED
Tuesday, June 2, 2026ASSIGNED TO EXAMINER
Wednesday, June 3, 2026NON-FINAL ACTION WRITTEN
Wednesday, June 3, 2026NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 4, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 4, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 4, 2026TEAS/EMAIL CORRESPONDENCE ENTERED